ANGPTL2 and lung cancer: demonstrated that angiopoietin-like 2 enhances endothelial cell migration and angiogenesis by stimulating VEGF‐A production in human lung cancer cells, facilitating lymphangiogenesis through the integrin α5β1, p38 and NF-κB pathways [57].